Live Breaking News & Updates on Olivier Clerc

Stay updated with breaking news from Olivier clerc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Attralus Announces New Clinical Data in ATTR CM and AL With AT-01 (Iodine (I-124) Evuzamitide), a Novel Amyloid-Specific Imaging Agent

AT-01 shows increased LV uptake and LV amyloid activity in all cardiac ATTR and AL subjects, but in none of the controls (100% accuracy) AT-01 demonstrates ....

United States , Baden Wüberg , San Francisco , Olivier Clerc , Luke Heagle , Sharmila Dorbala , Gregory Bell , International Symposium On Amyloidosis , Research Fellow Amyloidosis Program , Outcomes Research Poster Abstracts , Nuclear Cardiology , Attralus Inc , Healthcare Pharmaceuticals Industry , University Of Tennessee Research Foundation , American Society Of Nuclear Cardiology , International Symposium , American Society , Principal Investigator , Chief Medical Officer , Poster Presentation , Basic Science , Left Ventricular Amyloid , Echocardiography Study , Research Poster , Pan Amyloid Diagnostic , Tennessee Research ,

Attralus Announces New Clinical Data in ATTR CM and AL With

AT-01 shows increased LV uptake and LV amyloid activity in all cardiac ATTR and AL subjects, but in none of the controls (100% accuracy)AT-01 demonstrates. ....

United States , Baden Wüberg , San Francisco , Olivier Clerc , Luke Heagle , Sharmila Dorbala , Gregory Bell , International Symposium On Amyloidosis , Attralus Inc , Research Fellow Amyloidosis Program , University Of Tennessee Research Foundation , Outcomes Research Poster Abstracts , Nuclear Cardiology , American Society Of Nuclear Cardiology , International Symposium , American Society , Principal Investigator , Chief Medical Officer , Poster Presentation , Basic Science , Left Ventricular Amyloid , Echocardiography Study , Research Poster , Pan Amyloid Diagnostic , Tennessee Research , Systemic Amyloidosis ,

Attralus to Present New Data on Its Amyloidosis Portfolio at the 2022 International Symposium on Amyloidosis

Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today ....

Baden Wüberg , San Francisco , United States , Arnt Kristen , Ashutosh Wechalekar , Luke Heagle , Christophe Sirac , Alan Stuckey , Manasi Balachandran , Emily Martin , Olivier Clerc , J Steve Foster , Neue Universit , R Eric Heidel , Gregory Bell , Marina Ramirez Alvarado , Morie Gertz , International Symposium On Amyloidosis , University College London , Research Fellow Amyloidosis Program , International Society Of Amyloidosis , Attralus Inc , University Hospital Heidelberg Universit , University Of Tennessee Research Foundation , Cancer Theranostics Program Session , University Of Limoges ,

Attralus to Present New Data on Its Amyloidosis Portfolio

SAN FRANCISCO, Aug. 22, 2022 (GLOBE NEWSWIRE) Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to. ....

Baden Wüberg , Arnt Kristen , Ashutosh Wechalekar , Christophe Sirac , Alan Stuckey , Manasi Balachandran , Emily Martin , J Steve Foster , Olivier Clerc , Neue Universit , R Eric Heidel , Gregory Bell , Marina Ramirez Alvarado , Morie Gertz , International Symposium On Amyloidosis , University College London , Research Fellow Amyloidosis Program , International Society Of Amyloidosis , Attralus Inc , University Hospital Heidelberg Universit , University Of Tennessee Research Foundation , Cancer Theranostics Program Session , University Of Limoges , University Of Tennessee Graduate School Medicine , Cancer Theranostics Program , Tennessee Graduate School ,